Skip to main content

Post-IPO Debt Biotechnology Companies

Explore 90 biotechnology startups that raised post-ipo debt funding. Access verified founder contact information and fundraising data.

Total Companies
90
Total Funding
$2.9B
Avg Funding
$116.3M
Cities
20

Export 90 Post-IPO Debt Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Cambridge, United States
$125.0M
raised

KalVista Pharmaceuticals focuses on developing oral medicines, particularly for managing hereditary angioedema.

Sep 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$7.4M
raised

NuGen Medical Devices develops needle-free technologies and medical delivery products.

Sep 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$7.3M
raised

Clearmind is a psychedelic medicine biotech company that focuses on the discovery and development of novel psychedelic derived therapeutics.

Sep 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$10.0M
raised

EGF Theramed Health is a consumer technology company engaged in the provision of biomedical online services.

Sep 2022
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

$479K
raised

Earth Alive Clean Technologies develops and manufactures a variety of state-of-the-art microbial technology-based products.

Sep 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 90 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
$5.8M
raised

MindMaze formerly Relief Therapeutics develops biopharmaceutical and neurotechnology solutions for neurological and rare diseases.

Aug 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Baltimore, United States
$10.0M
raised

Cerecor discovers, develops and commercializes neuroscience drugs.

Aug 2021
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Caledon, Canada
$78.6M
raised

HLS is dedicated to the stewardship of branded pharmaceuticals through their life cycles post - exclusivity.

Aug 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Lexington, United States
$125.0M
raised

ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.

Aug 2024
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ansager, Denmark
$315K
raised

Dancann Pharma manufactures medical cannabis and develops novel cannabinoid therapeutics for a broad range of diseases.

Jul 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 90 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
New York, United States
$125.0M
raised

MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.

Jul 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$50.0M
raised

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

Jul 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Leeds, United Kingdom
$29.9M
raised

4D Pharma PLC is a world leader in the development of live biotherapeutics.

Jul 2021
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Conshohocken, United States
$350.0M
raised

Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.

Jul 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$7.0M
raised

Biotechnology company engaged in the extraction and distribution of psychoactive compounds, and developing natural health care products.

Jul 2022
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 90 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$105.0M
raised

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

Jul 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Alpharetta, United States
$3.0M
raised

Clearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.

Jul 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$2.1M
raised

Gemina Labs is a transformative biochemistry firm that develops next-generation testing platforms for detecting pathogens.

Jul 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Allschwil, Switzerland
$313.9M
raised

The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

San Diego, United States
$150.0M
raised

Maravai is a life sciences company providing critical products to enable the development of drug therapies, diagnostics, novel vaccines.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 90 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Radnor, United States
$500.0M
raised

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Hamel, United States
$500.0M
raised

Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Melbourne, Australia
$658K
raised

Rhythm Biosciences is a meditech company that commercializes medical diagnostics technology.

Jun 2025
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Emeryville, United States
$200.0M
raised

4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Emeryville, United States
$200.0M
raised

4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

Jun 2026
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 90 companies

Ready to Connect with Post-IPO Debt Biotechnology Startups?

Get verified founder emails, funding details, and company data for 90 post-ipo debt biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked